Laurent De Grauwe

Co-Founder and CEO @ Justifai | Product, Growth, AI Governance | ex-Microsoft

Driving Innovation and Growth in Tech: From Startups to Global Enterprises

Global Sales & Marketing Leader: With over 20 years of experience, I've driven transformative growth across Cloud Computing, IoT, Data and AI, and Enterprise Software.

Strategic Thinker: From Microsoft to startups, I've consistently scaled businesses of all sizes. Key achievements include:
- Achieving first $1M ARR in startups
- Growing incubation workloads to +$100M
- Transforming products into multi-billion dollar businesses

Go-To-Market Specialist: Expert in crafting and executing global GTM strategies that deliver exponential growth. I've led teams to success in small and highly matrixed organizations.

Business Developer at heart: I thrive where routes to market are yet to be defined. I am a quick learner and able to pivot based on market context.

Authentic Leader: Empowering people to accelerate business growth. Passionate coach, focusing on individual strengths and adapting leadership style for maximum effectiveness.

Sr. Director Global Field GTM & Programs 

The Netherlands Authority for Consumers and Markets

I focus on the tooling to make analyses reproducible by integration of MLOps/DevOps techniques (e.g., Docker, Poetry, Kubernetes) and performing case analyses.

Senior Data Scientist

Omina Technologies Machine Learning

Head of Life Sciences

Machine Learning Engineer

Ludger Limited

I am responsible for implementing high-throughput quantitation for all the measurements techniques that are used by Ludger Ltd, while at the same time expanding on their functionality. For example, including fragmentation information to the profiling software that I have previously developed will provide us with more information regarding peak identity of signals that we observe in a mass spectrum.

Additionally, I have been involved in several projects regarding bio-marker discovery using various statistical and mathmetical techniques such as Survival Analysis, Regression (Cox, Logistic, etc), Clustering (PCA, PLSDA, FAMD) and this has lead to the discovery of a biomarker for IBD Escalation which has since been patented by Ludger Ltd.

Lastly, I was responsible for the development of a proof-of-principle graph database based system that will be used to gather multiomics data, and perform big data based analyses on the data in an attempt to uncover previously unknown correlations.

Bioinformatician

Genos Ltd

I was hired by Genos to implement some of the methods that were developed during my PhD research at the LUMC, with the purpose of establishing an IgG mouse glycopeptide profiling method.

Researcher

Leiden University Medical Center

My PhD research has focussed on developing automated methods for the quantitation of glycans and glycopetides. This reseach has resulted into two open source software packages, namely MassyTools and LaCyTools. Furthermore, I have applied the developed methodology to a cohort of healthy pregnant women (study glycosylation changes during pregnancy) and a cohort containing maternal and umbilical cord blood (study differences between maternal and foetal glycosylation).

PhD Researcher

I finished my computer science studies as a 'duaal'-student, meaning that I worked for KPN for 3 days a week and studied at the 'The Hague University of Applied Sciences' for 2 days a week. The 'duaal'-student project was a high profile opportunity where KPN tried to recruit high potential employees at an early timepoint, with a strict selection process.

I worked at two different departments during the two years, i.e. process development (department responsible for the design and implementation of new processes) and system management (department responsible for maintaining the systems used by KPN).

Software Developer

Director of healthcare and life sciences based AI research, with a strong focus on trustworthy AI (Explainable, Ethical and Regulatory compliant) that have a meaningful impact on the quality of healthcare and patient quality of life.

I have given presentations at various global venues discussing my views, and presented steps on how to move from a reactive population based healthcare system to a pro-active, personalised healthcare system, with being a panelist as part of the Belgian Economic Mission to the USA as a major milestone. Here, I discussed why adoption of AI by healthcare has not been as broad over the past decades and what has (to) change to ensure a wide-scale adoption of AI, to fully utilise all the patient (and wider) data available.

taplio

The Battle

Laurent De Grauwe

Bas Jansen

Followers

Posts

Engagements

Likes

Ready to grow your LinkedIn presence?